D.E. Shaw & Co’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-72
| Closed | -$104K | – | 3888 |
|
|
2022
Q2 | $104K | Sell |
72
-39
| -35% | -$56.3K | ﹤0.01% | 3547 |
|
|
2022
Q1 | $232K | Sell |
111
-5
| -4% | -$10.5K | ﹤0.01% | 3551 |
|
|
2021
Q4 | $570K | Buy |
116
+56
| +93% | +$275K | ﹤0.01% | 3033 |
|
|
2021
Q3 | $378K | Buy |
60
+53
| +757% | +$334K | ﹤0.01% | 2962 |
|
|
2021
Q2 | $63K | Buy |
+7
| New | +$63K | ﹤0.01% | 3397 |
|